Soltis Investment Advisors’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,406
Closed -$653K 598
2025
Q4
$653K Sell
7,406
-97
-1% -$8.26K 0.04% 278
2025
Q3
$624K Buy
7,503
+22
+0.3% +$1.92K 0.04% 273
2025
Q2
$699K Hold
7,481
0.05% 212
2025
Q1
$791K Hold
7,481
0.07% 188
2024
Q4
$724K Buy
7,481
+62
+0.8% +$6.18K 0.07% 197
2024
Q3
$733K Hold
7,419
0.07% 180
2024
Q2
$638K Hold
7,419
0.07% 185
2024
Q1
$562K Buy
7,419
+2,065
+39% +$159K 0.06% 192
2023
Q4
$407K Sell
5,354
-150
-3% -$10.5K 0.05% 203
2023
Q3
$380K Buy
+5,504
New +$396K 0.05% 197
2021
Q2
Sell
-5,501
Closed -$329K 248
2021
Q1
$329K Sell
5,501
-660,816
-99% -$37.9M 0.06% 174
2020
Q4
$37M Buy
666,317
+659,816
+10,149% +$34.1M 6.85% 3
2020
Q3
$283K Sell
6,501
-746
-10% -$33.7K 0.07% 171
2020
Q2
$331K Sell
7,247
-2,266
-24% -$91.4K 0.09% 145
2020
Q1
$297K Sell
9,513
-798,564
-99% -$28.4M 0.09% 120
2019
Q4
$25.2M Buy
+808,077
New +$23.1M 4.86% 4

Other funds holding MMSI

Soltis Investment Advisors's MMSI Position: Q1 2026 in Review

Soltis Investment Advisors sold out of Merit Medical Systems (MMSI) in Q1 2026, closing a stake of 7,406 shares — an estimated $653K sold.

Soltis Investment Advisors first reported a position in MMSI in Q4 2019 and held it in 16 quarters. The position peaked at $37M in Q4 2020. 399 funds tracked by Wall St. Rank hold MMSI as of Q1 2026.

  • Soltis Investment Advisors reported no remaining Merit Medical Systems position as of Q1 2026 after selling out during the quarter.
  • Soltis Investment Advisors sold 7,406 Merit Medical Systems shares in Q1 2026, an estimated $653K.
  • Soltis Investment Advisors first reported a position in Merit Medical Systems in Q4 2019 and held it in 16 quarters.
  • Soltis Investment Advisors's Merit Medical Systems position peaked at $37M in Q4 2020.
  • 399 funds tracked by Wall St. Rank held Merit Medical Systems as of Q1 2026.

Based on Soltis Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.